Cite

HARVARD Citation

    Joseph, S. et al. (n.d.). OC 8491 PREPVacc: a phase III, MAMS adaptive prophylactic HIV vaccine trial with a second randomisation to compare F/TAF with TDF/FTC prep. BMJ global health. p. A10. [Online]. 
  
Back to record